#diabetes management #Vienna #Austria #Sinocare #iCan CGM

Sinocare’s Impact at EASD 2025

The European Association for the Study of Diabetes (EASD) held its 61st annual meeting in Vienna, Austria, showcasing innovative contributions in diabetes management. Among the prominent participants was Sinocare, whose comprehensive solutions received significant attention during the conference.

At the heart of Sinocare's presentation was the next-generation iCan i6 Continuous Glucose Monitoring (CGM) system. This system promises smarter monitoring and an improved user experience. Highlighted features include a lightweight and compact sensor that allows for effortless one-step application, ensuring ease of use for patients. The iCan i6 also supports 27 languages, enhancing accessibility for users all around the globe. Furthermore, it incorporates a built-in altitude compensation algorithm to ensure accurate readings even at high elevations, making it suitable for travelers and those living in mountainous regions. This is particularly relevant for individuals with diabetes who wish to maintain active lifestyles without cumbersome monitoring devices.

Sinocare’s booth was not just about showcasing products; it served as a hub for knowledge exchange and networking. During a specialized symposium, renowned experts such as Professor Lori Laffel, Dr. Guido Freckmann, and Professor Julia Mader presented pivotal research findings relating to the efficacy of the iCan CGM system. Their discussions focused on critical topics like performance, practicality, and pediatric applications of CGM technology. They shared promising data from recent studies conducted in Germany and the USA, which examined the performance of the iCan system in both adult and pediatric populations.

An intriguing aspect of the symposium was the potential of diabetes technology to impact the travel and employment prospects for individuals with diabetes, especially those aspiring to fly. The discussions brought to light how modern advancements in diabetes management could open new opportunities for personal and professional growth in an increasingly mobile world.

In addition to the iCan i6, Sinocare's exclusive partner, A. Menarini Diagnostics, introduced the GlucoMen iCan CGM system. This presentation captivated the attention of healthcare professionals present, showcasing the system's latest enhancements and clinical advantages through an immersive booth design.

Innovative Ecosystem for Diabetes Management

Another highlight of Sinocare's engagement at EASD was a private dinner seminar where they unveiled their new diabetes care ecosystem, called 'A+C'. This integrated solution combines non-invasive AGEscan screening with CGM technology, allowing for early risk detection and precise intervention. This innovative approach signifies a step forward in diabetes prevention strategies, emphasizing the importance of proactive health management.

Sinocare also demonstrated its glucose management solutions tailored for hospital settings, which seamlessly bridge outpatient and inpatient scenarios. This connectivity aims to improve overall healthcare efficiency and enhance patient care quality.

By participating in EASD 2025, Sinocare not only showcased their cutting-edge technology but also reinforced their commitment to advancing global collaboration with experts in the field. They have beautifully illustrated how technological innovation can be intricately tied to the needs of patients and healthcare providers alike.

Through their innovative presentations and solutions, Sinocare is set to make a lasting impact on diabetes management and prevention strategies, paving the way for improved outcomes for individuals living with diabetes worldwide.